Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
NYD's Profile
Displaying 101-150 of 777 result(s).
GNBTQ Generex Biotechnology Corp.
01/06/2022 1:42:45 PM
The problem with the current COVID (3)
GNBTQ Generex Biotechnology Corp.
01/05/2022 3:26:25 PM
I don't think anyone is surprised.
GNBTQ Generex Biotechnology Corp.
01/04/2022 3:42:28 PM
If the company has the flexibility (3)
GNBTQ Generex Biotechnology Corp.
01/04/2022 2:32:08 PM
CYDY has issued a statement that th (1)
GNBTQ Generex Biotechnology Corp.
01/04/2022 1:39:37 PM
It's both amazing & disheartening h (2)
GNBTQ Generex Biotechnology Corp.
01/04/2022 1:06:25 PM
Thanks,
GNBTQ Generex Biotechnology Corp.
01/04/2022 10:17:09 AM
If I'm not mistaken (don't hold me (1)
GNBTQ Generex Biotechnology Corp.
01/04/2022 9:34:49 AM
Well, since they are not reporting (2)
GNBTQ Generex Biotechnology Corp.
01/03/2022 2:44:50 PM
Just another reason for GNBT/NGIO t (4)
GNBTQ Generex Biotechnology Corp.
01/03/2022 1:53:03 PM
Unfortunately, this is probably the (1)
GNBTQ Generex Biotechnology Corp.
01/03/2022 10:29:50 AM
They are not making any disclosures (1)
GNBTQ Generex Biotechnology Corp.
12/30/2021 8:27:23 AM
I agree H. Unfortunately it appears (3)
GNBTQ Generex Biotechnology Corp.
12/29/2021 8:58:21 AM
If this is all about the lack of mo (5)
GNBTQ Generex Biotechnology Corp.
12/28/2021 6:21:07 PM
Well, you may be right, maybe there (1)
GNBTQ Generex Biotechnology Corp.
12/28/2021 2:22:12 PM
That's the million dollar question. (1)
GNBTQ Generex Biotechnology Corp.
12/28/2021 11:22:54 AM
In light of what's going on, I don' (1)
GNBTQ Generex Biotechnology Corp.
12/28/2021 11:21:02 AM
You know, nobody really knows what (1)
GNBTQ Generex Biotechnology Corp.
12/28/2021 11:10:32 AM
I hear you. At this point, we have (2)
GNBTQ Generex Biotechnology Corp.
12/28/2021 10:22:54 AM
I put another order in again today (2)
GNBTQ Generex Biotechnology Corp.
12/28/2021 10:19:38 AM
Now that's funny. But in all seriou (1)
GNBTQ Generex Biotechnology Corp.
12/28/2021 10:14:27 AM
Agree! It's time to clean house! We (1)
GNBTQ Generex Biotechnology Corp.
12/28/2021 10:01:12 AM
Well, it's in the 4's and dropping. (2)
GNBTQ Generex Biotechnology Corp.
12/28/2021 8:18:10 AM
Well, I certainly never expected to (2)
GNBTQ Generex Biotechnology Corp.
12/27/2021 9:21:10 PM
I certainly hope it doesn't drop th (1)
GNBTQ Generex Biotechnology Corp.
12/27/2021 8:59:48 PM
Good research. Looks like it starts (1)
GNBTQ Generex Biotechnology Corp.
12/27/2021 7:46:03 PM
There's no doubt in my mind that th (2)
GNBTQ Generex Biotechnology Corp.
12/27/2021 6:21:46 PM
As far as Joe, I've had good conver (3)
GNBTQ Generex Biotechnology Corp.
12/27/2021 2:12:26 PM
No doubt, 5's should not be accepte (2)
GNBTQ Generex Biotechnology Corp.
12/27/2021 1:43:21 PM
I believe I only mentioned bonuses (3)
GNBTQ Generex Biotechnology Corp.
12/27/2021 12:57:55 PM
Something is bad wrong when the com (2)
GNBTQ Generex Biotechnology Corp.
12/27/2021 9:49:35 AM
Let's hope what Todd said is true & (2)
GNBTQ Generex Biotechnology Corp.
12/27/2021 9:32:51 AM
When folks depart a company quietly (3)
GNBTQ Generex Biotechnology Corp.
12/23/2021 3:13:40 PM
Regardless of any restrictions, you (2)
GNBTQ Generex Biotechnology Corp.
12/23/2021 2:58:12 PM
Looks like the fireside sale is hap
GNBTQ Generex Biotechnology Corp.
12/23/2021 11:19:15 AM
You can't blame folks for believing (1)
GNBTQ Generex Biotechnology Corp.
12/23/2021 8:56:41 AM
At least there's one thing good, th (2)
GNBTQ Generex Biotechnology Corp.
12/22/2021 2:24:50 PM
I never thought I would have said 3 (2)
GNBTQ Generex Biotechnology Corp.
12/22/2021 9:37:39 AM
Facts matter, and what he said is a (3)
GNBTQ Generex Biotechnology Corp.
12/21/2021 9:25:42 PM
You implied in your post you went b (1)
GNBTQ Generex Biotechnology Corp.
12/21/2021 3:43:47 PM
"when Moscato would have replied "t (2)
GNBTQ Generex Biotechnology Corp.
12/21/2021 2:24:26 PM
When you figure it out, let us all (2)
GNBTQ Generex Biotechnology Corp.
12/21/2021 1:11:20 PM
Since the SEC investigations are no (2)
GNBTQ Generex Biotechnology Corp.
12/21/2021 12:44:21 PM
I thought I had a general understan (2)
GNBTQ Generex Biotechnology Corp.
12/21/2021 11:59:27 AM
Let's all look at this from a "comm (2)
GNBTQ Generex Biotechnology Corp.
12/20/2021 2:17:35 PM
I agree with you, that's why I said (1)
GNBTQ Generex Biotechnology Corp.
12/20/2021 12:16:43 PM
We are in the 6's again! No doubt g (1)
GNBTQ Generex Biotechnology Corp.
12/20/2021 12:12:09 PM
Very Sad. No doubt, things just kee (1)
GNBTQ Generex Biotechnology Corp.
12/18/2021 8:07:18 AM
Every year doctors predict the next (4)
GNBTQ Generex Biotechnology Corp.
12/18/2021 7:49:27 AM
Agree, natural immunity is very eff (2)
GNBTQ Generex Biotechnology Corp.
12/17/2021 7:58:59 PM
At my work there was a big push to (6)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • Vitalik Buterin Highlights Security Risks of AI Technology
  • Urgent Alert: Investors Advised to Act on Charter Communications
  • Class Action Filed Against Snap, Inc. for Investor Securities Fraud
  • Navigating Legal Proceedings: Insights for RxSight Investors
  • LifeMD Investors Urged to Act Before Critical Deadline
  • Investors Urged to Act: Lockheed Martin Securities Class Action
  • Upcoming Class Action Lawsuit Against C3.ai, Inc. Explained
  • Radioligand Therapy Market Growth Forecast to $10.9 Billion
  • How to Integrate a Copilot into Your Enterprise Software Ecosystem
  • Unraveling Trump's $2 Trillion Strategy for Tech Dominance
  • Rapid Growth of Solar Container Market Expected by 2030
  • Urgent Investor Alert: Legal Claims for Quantum Corporation Stakeholders
  • Legal Challenges Faced by LifeMD, Inc. Over Market Performance
  • Community of Investors Rally as Sable Offshore Corp Faces Class Action
  • Understanding the Class Action Lawsuit Filed Against Dow Inc.
  • Understanding the SelectQuote Class Action Lawsuit Details
  • Class Action Lawsuit Against PubMatic: What Investors Need to Know
  • Investors Urged to Take Action as Deadline Approaches
  • Future Insights: Enterprise Asset Management Market Growth
  • Grant Cardone Questions Value of College Degrees Amidst AI Growth
  • Zetrix AI and Malaysia Unite to Pioneer Shariah AI Standards
  • How to Automate Crypto Trading with Trading Bots + RDP Server
  • Urgent Investor Alert: Action Needed for CTO Realty Growth Stakeholders
  • AION V Earns Prestigious Euro NCAP Five-Star Safety Rating
  • Critical Class Action Update for Charter Communications Investors
  • Faruqi & Faruqi Investigates Fiserv for Investors Affected
  • Zetrix AI and Government Join Forces for Ethical AI Standards
  • Geely Automobile Holdings Faces Investigation Amid Allegations
  • Class Action Alert for Investors in Easterly ROCMuni Fund
  • Marex Group PLC Faces Scrutiny Over Financial Practices
  • Investors Eye PACS Group, Inc. Amid Claims Investigation
  • Anika Therapeutics Faces Investigation Amidst Recent Setback
  • Class Action Lawsuit Against CTO Realty Growth: Key Insights
  • Faruqi & Faruqi, LLP Takes Action for Replimune Investors
  • Investors Urged to Act Amid KinderCare Class Action Lawsuit
  • Solid State Relay Market Growth Driven by Innovative Trends
  • Deadline Looms for Altimmune Investors: Key Details to Know
  • Investigating Barnes & Noble Education: Concerns for Investors
  • Investor Insight: MarineMax Faces Legal Scrutiny Amid Challenges
  • Investigation Into Innovative Solutions and Support, Inc. Investors
  • Understanding Exelixis' Recent Financial Challenges and Investor Concerns
  • Investors Monitor Molina Healthcare for Stock Performance Trends
  • Investigation Launched for Albany International Corp. - AIN
  • Investigation Launched for Investors in Praxis Precision Medicines
  • Investigation Into Capricor Therapeutics Sparks Investor Concerns
  • Legal Alert: Charter Communications Class Action Notification
  • RxSight, Inc. Faces Class Action Lawsuit Amid Financial Challenges
  • Investigation into Fortinet, Inc.: Shareholder Concerns Rise
  • Align Technology Faces Investigation As Financial Results Miss Targets
  • Savara Inc. Faces Class Action Lawsuit from Pomerantz LLP
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site